1. Home
  2. MWA vs DNTH Comparison

MWA vs DNTH Comparison

Compare MWA & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MUELLER WATER PRODUCTS

MWA

MUELLER WATER PRODUCTS

HOLD

Current Price

$25.24

Market Cap

3.9B

Sector

Industrials

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$107.16

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MWA
DNTH
Founded
1857
2015
Country
United States
United States
Employees
3500
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.5B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
MWA
DNTH
Price
$25.24
$107.16
Analyst Decision
Buy
Strong Buy
Analyst Count
2
13
Target Price
$30.50
$121.00
AVG Volume (30 Days)
1.0M
857.6K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
1.01%
N/A
EPS Growth
64.86
N/A
EPS
0.65
N/A
Revenue
$1,429,700,000.00
$2,036,000.00
Revenue This Year
$4.78
N/A
Revenue Next Year
$4.27
$29.48
P/E Ratio
$38.40
N/A
Revenue Growth
8.75
N/A
52 Week Low
$22.74
$18.08
52 Week High
$31.00
$112.27

Technical Indicators

Market Signals
Indicator
MWA
DNTH
Relative Strength Index (RSI) 48.78 64.55
Support Level $25.11 $79.27
Resistance Level $26.05 N/A
Average True Range (ATR) 0.58 5.96
MACD 0.05 0.53
Stochastic Oscillator 38.49 87.94

Price Performance

Historical Comparison
MWA
DNTH

About MWA MUELLER WATER PRODUCTS

Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments: Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: